Keyphrases
MD Anderson Cancer Center
100%
Multiple Myeloma
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Center Experience
100%
Pretransplant
85%
Overall Survival
71%
Minimal Residual Disease
71%
Very Good Partial Response
71%
Progression-free Survival
57%
Confidence Interval
42%
High-risk Cytogenetics
42%
Disease Status
28%
Hazard Ratio
28%
Multivariate Analysis
28%
Univariate Analysis
28%
Multiple Myeloma Patients
28%
Lenalidomide
28%
Fluorescence in Situ Hybridization
14%
Poor Outcome
14%
Myeloma
14%
Non-associated
14%
High Risk
14%
Standard of Care
14%
Bone Marrow Biopsy
14%
Transplantation
14%
Survivors
14%
Immune Therapy
14%
Hematological Response
14%
Median Progression-free Survival
14%
Retrospective Analysis
14%
Cell Therapy
14%
Improved Outcomes
14%
Novel Agents
14%
Design Requirements
14%
Chromosome 14
14%
Chromosome 4
14%
High-risk Myeloma
14%
Post-transplant Outcomes
14%
Next-generation Flow Cytometry
14%
Medicine and Dentistry
Malignant Neoplasm
100%
Multiple Myeloma
100%
Autologous Stem Cell Transplantation
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Overall Survival
83%
Progression Free Survival
83%
Minimal Residual Disease
83%
Hazard Ratio
33%
Multivariate Analysis
33%
Univariate Analysis
33%
Lenalidomide
33%
Flow Cytometry
16%
Myeloma
16%
Bone Marrow Biopsy
16%
Immunotherapy
16%
Fluorescence in Situ Hybridization
16%
Cell Therapy
16%
Chromosome 4
16%
Chromosome 14
16%
Anesthesia Induction
16%
Immunology and Microbiology
Multiple Myeloma
100%
Autologous Stem Cell Transplantation
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Overall Survival
83%
Progression Free Survival
83%
Lenalidomide
33%
Immunity
16%
Fluorescence in Situ Hybridization
16%
Chromosome 14
16%
Chromosome 4
16%
Biochemistry, Genetics and Molecular Biology
Autologous Stem Cell Transplantation
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Overall Survival
83%
Progression Free Survival
83%
Cytogenetics
50%
Multivariate Analysis
33%
Fluorescence in Situ Hybridization
16%
Immunity
16%
Flow Cytometry
16%
Chromosome 14
16%
Chromosome 4
16%